Articles written for the GLP list the source as Genetic Literacy Project. All other articles were written for the sources noted with excerpts provided by the GLP.

FDA action against 23andMe doesn’t signal the end for personal genomics

Jennifer K. Wagner | 
Many have speculated that the FDA action against 23andMe spells an end for personal genomics. But according to a new ...

Is the ‘designer baby’ debate more about gene patentability?

Jonathan Webber | 
The controversial "designer baby" debate speaks to the larger issues about patent eligibility and the patent application process, according to ...
Sequencing Money x

Genetic testing service deCODEme shutting down in wake of Amgen/deCODE deal

Dan Vorhaus | 
After the $415 million sale of deCODE Genetics to Amgen, deCODE's deCODEme direct-to-consumer genomic screening service will be shut down ...

Amgen buys deCODE: What are the implications for genetic testing customers?

Dan Vorhaus | 
The big biotech news of the day is the $415 million sale of deCODE Genetics to Amgen. Coverage of the ...